chronic
hepat
c
caus
infect
hepat
c
viru
hcv
global
health
problem
use
mous
model
hepat
c
examin
therapeut
effect
recombin
vaccinia
viru
rvv
encod
hcv
protein
gener
immunocompet
mice
express
multipl
hcv
protein
via
creloxp
switch
system
establish
sever
distinct
attenu
rvv
strain
hcv
core
protein
express
consist
liver
polyinosin
acidpolycytidyl
acid
inject
mice
show
chronic
hepat
crelat
patholog
find
hepatocyt
abnorm
accumul
glycogen
steatosi
liver
fibrosi
hepatocellular
carcinoma
immun
one
rvv
strain
encod
nonstructur
hcv
protein
suppress
serum
inflammatori
cytokin
level
allevi
symptom
patholog
chronic
hepat
c
within
day
inject
furthermor
hcv
protein
level
liver
tissu
also
decreas
tcelldepend
manner
consist
result
show
immun
induc
robust
tcell
immun
respons
specif
hcv
nonstructur
protein
also
demonstr
onset
chronic
hepat
mxcre
mice
mainli
attribut
inflammatori
cytokin
tumor
necrosi
factor
tnfa
interleukin
thu
gener
mice
model
use
investig
immunolog
process
associ
persist
express
hcv
protein
mice
develop
immun
toler
hcv
antigen
addit
propos
could
develop
effect
therapeut
vaccin
hepat
c
viru
hcv
major
public
health
problem
approxim
million
peopl
infect
hcv
worldwid
hcv
caus
persist
infect
lead
chronic
liver
diseas
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
hcc
antivir
drug
highli
effect
individu
chronic
infect
furthermor
effect
vaccin
hvc
develop
conveni
anim
model
hcv
infect
greatli
facilit
develop
effect
hcv
vaccin
transgen
mice
express
hcv
protein
gener
studi
hcv
express
howev
case
relev
transgen
express
embryon
develop
therefor
transgen
mice
becom
immunotoler
transgen
product
consequ
adult
mice
use
investig
pathogenesi
chronic
hepat
c
address
problem
develop
system
drive
condit
express
hcv
transgen
system
involv
creloxp
system
recombin
adenoviru
capabl
express
cre
recombinas
concern
express
adenoviru
transient
express
hcv
protein
could
induc
immun
respons
therefor
obscur
evid
effect
host
immun
respons
chronic
liver
patholog
therefor
use
creloxp
switch
system
gener
immunocompet
mous
model
hcv
protein
express
system
could
studi
host
immun
respons
hcv
protein
folgori
et
al
report
effect
vaccin
chimpanze
adenovir
vector
plasmid
dna
encod
hcv
nonstructur
region
techniqu
protect
liver
tissu
acut
hepat
result
whole
anim
challeng
viru
howev
vaccin
yet
shown
effect
chronic
hcv
infect
aim
address
hcv
express
caus
chronic
liver
diseas
provid
new
option
hcv
vaccin
develop
use
highli
attenu
strain
vaccinia
viru
vv
gener
three
recombin
vaccinia
virus
rvv
encod
one
three
differ
hcv
protein
found
one
recombin
viru
encod
nonstructur
hcv
protein
resolv
patholog
chronic
hepat
c
symptom
liver
also
found
immun
suppress
hcv
core
protein
level
liver
transgen
mice
moreov
suppress
mediat
cell
previous
report
produc
adult
mice
express
hcv
transgen
bred
transgen
mice
carri
hcv
transgen
transgen
mice
express
cre
recombinas
respons
interferon
ifn
chemic
induc
ifna
poli
c
figur
follow
poli
c
inject
hcv
transgen
rearrang
hcv
sequenc
express
liver
progeni
mxcre
mice
within
day
poli
c
inject
figur
evalu
characterist
featur
mxcre
mice
analyz
serum
alanin
aminotransferas
alt
liver
hcv
core
protein
level
poli
c
inject
illustr
figur
serum
alt
level
increas
reach
peak
h
first
poli
c
inject
elev
appear
direct
result
poli
c
treatment
caus
liver
injuri
peak
serum
alt
level
drop
continu
day
alt
level
began
increas
hcv
core
protein
level
thereaft
hcv
core
protein
express
consist
least
day
histolog
analysi
show
hcv
core
protein
express
hepatocyt
transgen
mice
mice
show
evid
lymphocyt
infiltr
caus
hcv
core
protein
figur
e
observ
addit
modifi
histolog
activ
index
hai
score
indic
express
hcv
protein
caus
chronic
hepat
mxcre
mice
weak
though
persist
immun
respons
follow
initi
bout
acut
hepat
figur
moreov
observ
number
patholog
chang
mice
includ
swell
hepatocyt
abnorm
architectur
livercel
cord
abnorm
accumul
glycogen
steatosi
fibrosi
hcc
figur
f
tabl
steatosi
mild
younger
mice
day
becam
increasingli
sever
time
day
figur
importantli
none
patholog
chang
observ
mxcre
mice
poli
c
inject
figur
determin
whether
activ
host
immun
respons
caus
reduct
hcv
protein
level
liver
mxcre
mice
use
highli
attenu
vv
strain
gener
three
rvv
rvv
encod
differ
hcv
protein
encod
mainli
structur
protein
encod
nonstructur
protein
encod
entir
hcv
protein
region
figur
rvv
express
varieti
protein
induc
strong
longterm
immun
evalu
potenti
prophylact
vaccin
use
western
blot
confirm
hcv
protein
express
cell
line
seven
protein
core
recogn
label
separ
cognat
antibodi
direct
figur
induc
effect
immun
respons
hcv
protein
transgen
mice
inject
rvvhcv
control
intraderm
mxcre
mice
day
poli
c
inject
figur
analysi
liver
section
day
immun
reveal
dramat
improv
varieti
patholog
find
associ
chronic
hepat
includ
piecem
necrosi
hepatocyt
swell
abnorm
architectur
livercel
cord
abnorm
accumul
glycogen
steatosi
figur
collect
result
demonstr
treatment
result
histolog
chang
indic
improv
chronic
hepat
suffer
transgen
mice
determin
whether
treatment
induc
effect
strain
hcv
transgen
mice
analyz
mxcre
mice
express
hcv
protein
mice
chronic
hepat
resolv
within
day
immun
taken
togeth
find
indic
dramat
therapeut
effect
type
hcv
transgen
mice
figur
assess
detail
effect
rvvhcv
immun
hcv
protein
clearanc
liver
mxcre
mice
monitor
level
hcv
core
protein
liver
sampl
via
elisa
found
within
day
immun
hcv
core
protein
level
significantli
lower
liver
mice
control
mice
figur
immunohistochem
analysi
indic
within
day
immun
level
hcv
core
protein
substanti
lower
liver
mxcre
mice
control
mice
figur
importantli
neither
resolut
chronic
hepat
reduct
hcv
protein
level
observ
mice
treat
result
indic
hcv
nonstructur
protein
might
import
effect
therapeut
vaccin
contrast
encod
hcv
structur
nonstructur
protein
show
signific
effect
result
indic
hcv
structur
protein
might
inhibit
therapeut
effect
nonstructur
protein
therefor
may
import
exclud
hcv
structur
protein
aa
antigen
protein
develop
therapeut
vaccin
chronic
hepat
c
addit
measur
serum
alt
level
mxcre
mice
four
treatment
group
day
rvvhcv
immun
serum
alt
level
signific
cremedi
activ
transgen
unit
hcv
cdna
clone
downstream
cag
promot
neomycinresist
gene
neo
poli
pa
signal
flank
two
loxp
sequenc
cdna
contain
core
region
b
cremedi
genom
dna
recombin
poli
c
inject
genom
dna
extract
liver
tissu
analyz
quantit
rtdpcr
cremedi
transgen
recombin
transgen
almost
fulli
recombin
transgen
mous
liver
day
inject
case
n
mice
per
group
c
hcv
core
protein
express
sustain
least
day
poli
c
inject
immunohistochem
analysi
reveal
hepatocyt
express
hcv
core
protein
within
day
inject
e
liver
section
mxcre
mice
poli
c
inject
infiltr
lymphocyt
arrow
observ
day
hepatocellular
carcinoma
hcc
observ
day
contrast
patholog
chang
observ
mxcre
mice
inject
inset
imag
show
abnorm
mitosi
tumor
cell
f
hepatocyt
swell
abnorm
architectur
livercel
cord
silver
stain
well
abnorm
glycogen
accumul
pa
stain
observ
day
mxcre
mice
observ
steatosi
oilredo
stain
day
subsequ
fibrosi
azan
stain
day
scale
bar
indic
mm
ly
differ
mice
control
mice
figur
find
indic
treatment
caus
liver
injuri
antivir
effect
independ
hepatocyt
destruct
hypothes
reduct
level
hcv
core
protein
rvvhcvtreat
mice
caus
cytolyt
elimin
hepatocyt
express
hcv
protein
investig
hypothesi
conduct
rtdpcr
analysi
genom
dna
liver
sampl
mxcre
mice
recombin
transgen
similar
control
mice
day
immun
figur
also
measur
express
hcv
mrna
mxcre
mice
mxcre
mice
day
immun
hcv
mrna
level
differ
mxcre
control
mice
figur
result
indic
suppress
hcv
core
protein
express
could
control
posttranscript
level
viral
clearanc
usual
associ
tcell
activ
regul
cytolyt
noncytolyt
antivir
mechan
determin
whether
tcell
activ
requir
reduct
hcv
core
protein
level
liver
transgen
mice
analyz
core
protein
level
mxcre
mice
immun
absenc
cell
figur
expect
mice
lack
cell
fail
show
reduct
hcv
core
protein
level
figur
howev
mice
lack
either
tcell
patholog
chang
associ
chronic
hepat
resolv
follow
immun
steatosi
score
mice
significantli
lower
control
mice
figur
result
indic
cell
respons
amelior
histolog
find
inflammatori
cell
type
may
play
asyetunidentifi
role
resolut
patholog
chang
mice
found
hcv
protein
reduct
liver
requir
cell
test
whether
hcvspecif
cell
present
splenocyt
day
immun
determin
function
reactiv
hcvspecif
cell
perform
mobil
assay
intracellular
ifnc
stain
transgen
mice
express
hcv
structur
protein
region
howev
compris
isol
splenocyt
immun
mice
cocultur
cell
line
week
analyz
cytolyt
cell
activ
measur
use
marker
degranul
ratio
cell
cell
significantli
increas
splenocyt
cocultur
wherea
splenocyt
treat
rvv
detect
figur
b
c
result
indic
treatment
increas
frequenc
hcv
activ
cell
consist
result
ratio
ifnc
cell
cell
mice
also
significantli
higher
mice
treat
rvv
taken
togeth
find
indic
induc
effect
tcell
immun
respons
import
epitop
cell
determin
whether
treatment
affect
inflammatori
cytokin
product
measur
serum
level
inflammatori
cytokin
rvv
immun
serum
level
inflammatori
cytokin
increas
mxcre
mice
figur
figur
immun
affect
serum
level
inflammatori
cytokin
mxcre
mice
caus
return
cytokin
level
observ
wildtyp
untreat
mice
figur
wildtyp
mice
cytokin
level
remain
unchang
immun
figur
result
indic
inflammatori
cytokin
respons
liver
pathogenesi
transgen
mice
test
hypothesi
inflammatori
cytokin
respons
liver
pathogenesi
mxcre
mice
administ
transgen
mous
serum
intraven
nontransgen
mice
observ
develop
chronic
hepat
nontransgen
mice
within
day
serum
transfer
figur
c
find
consist
day
immun
scale
bar
indic
mm
c
mm
e
histolog
evalu
steatosi
liver
sampl
mxcre
mice
day
immun
signific
relationship
indic
pvalu
hypothesi
inflammatori
mediat
play
key
role
induc
hepat
furthermor
investig
whether
tnfa
play
particularli
critic
role
pathogenesi
chronic
hepat
transgen
mice
neutral
tnfa
block
receptor
liver
mice
expect
chronic
hepat
develop
mice
figur
e
next
determin
cell
popul
produc
tnfa
continu
hcv
express
mxcre
mice
isol
intrahepat
lymphocyt
ihl
label
macrophag
cell
antitnfa
antibodi
use
intracellular
cytokin
detect
method
macrophag
mxcre
mice
produc
small
amount
tnfa
mxcre
mice
produc
much
larger
amount
cytokin
figur
final
evalu
whether
treatment
affect
number
macrophag
cytokin
product
macrophag
specif
isol
ihl
mxcre
mice
day
immun
percentag
macrophag
among
ihl
product
macrophag
significantli
lower
mice
control
mice
figur
though
percentag
tnfaproduc
macrophag
significantli
differ
control
mice
p
treatment
appear
suppress
macrophag
result
demonstr
suppress
effect
activ
macrophag
indic
suppress
amelior
histolog
indic
chronic
hepat
variou
hcv
transgen
mous
model
develop
use
examin
immun
respons
hcv
express
effect
pathogen
hcv
protein
hepatocyt
howev
transgen
mice
develop
toler
hcv
protein
therefor
examin
immun
respons
hcv
protein
difficult
overcom
problem
immun
toler
mous
model
hcv
express
develop
hcv
model
mice
reli
condit
express
core
protein
creloxp
switch
system
show
inject
adcr
vector
enhanc
frequenc
hcvspecif
activ
cell
liver
mice
caus
liver
injuri
howev
adcr
adenoviru
vector
alon
caus
acut
hepat
wildtyp
mice
nevertheless
transgen
model
use
evalu
interact
host
immun
system
viral
protein
serum
alt
level
iul
hcv
core
protein
level
reduc
express
protein
transient
week
therefor
adcredepend
model
use
effect
investig
immun
respons
chronic
hcv
hepat
use
poli
c
induc
express
cre
recombinas
gener
hcv
transgen
mice
order
studi
effect
hcv
protein
confirm
mice
develop
chronic
activ
hepatitisinclud
steatosi
lipid
deposit
hepatocellular
carcinoma
patholog
find
transgen
mice
similar
human
chronic
hepat
c
therefor
mous
model
hcv
may
use
analyz
immun
respons
chronic
hepat
howev
experiment
result
obtain
mous
model
may
directli
translat
clinic
find
patient
hcv
infect
express
hcv
protein
liver
specif
mice
furthermor
poli
c
inject
activ
innat
immun
respons
consequ
might
induc
temporari
liver
injuri
addit
poli
c
inject
adjuv
effect
specif
stimul
signal
evalu
whether
poli
c
inject
caus
hepat
mxcre
mice
examin
serum
alt
level
liver
histolog
follow
poli
c
inject
found
follow
poli
c
inject
serum
alt
level
mxcre
mice
increas
reach
peak
one
day
inject
declin
day
day
elev
thereaft
timecours
indic
poli
c
inject
alon
induc
continu
liver
injuri
figur
base
find
believ
effect
poli
c
inject
mice
confound
analysi
chronic
hepat
immun
suppress
hcv
protein
level
liver
suppress
associ
amelior
patholog
chronic
hepat
find
see
figur
importantli
treatment
caus
liver
injuri
base
serum
alt
level
therefor
treatment
unlik
cytopath
effect
infect
hepatocyt
find
provid
strong
evid
treatment
effect
halt
progress
chronic
hepat
immun
plasmid
dna
recombin
vaccinia
viru
effect
induc
cellular
humor
immun
respons
exert
protect
effect
challeng
hcv
infect
howev
find
previou
studi
reveal
hcv
immun
uninfect
anim
immunetoler
anim
induc
hcvspecif
immun
respons
model
describ
anim
immun
compet
hcv
therefor
find
provid
import
evid
effect
treatment
chronic
hepat
addit
demonstr
treatment
absenc
cell
effect
hcv
clearanc
import
observ
indic
hcv
clearanc
mediat
cell
mani
studi
shown
spontan
viral
clearanc
acut
hcv
infect
character
vigor
broadli
reactiv
tcell
respons
hcv
clearanc
hepatocellular
cytotox
mediat
antigenspecif
cytotox
lymphocyt
ctl
consist
observ
treatment
effect
induc
accumul
cell
express
high
level
figur
immun
suppress
serum
inflammatori
cytokin
level
daili
cytokin
level
serum
mxcre
mice
week
follow
immun
valu
repres
mean
sd
n
reflect
concentr
rel
measur
day
broken
line
indic
baselin
data
wildtyp
mice
case
n
mice
per
group
b
liver
section
mxcre
mxcre
mice
c
histolog
activ
index
hai
score
liver
sampl
taken
mxcre
mxcre
mice
liver
section
mxcre
mice
tnfa
neutral
receptor
block
scale
bar
indic
mm
e
hai
score
liver
sampl
taken
mxcre
tnfa
neutral
receptor
block
tg
nontg
indic
mxcre
mxcre
respect
f
macrophag
main
produc
tnfa
mxcre
mice
follow
poli
c
inject
g
immun
reduc
number
macrophag
liver
sampl
mxcre
mice
suppress
tnfa
product
macrophag
figur
signific
relationship
indic
pvalu
ifncin
spleen
notabl
even
immun
frequenc
activ
cell
low
minimum
incub
requir
distinguish
differ
rvv
treatment
even
small
popul
specif
cell
play
relev
role
reduct
core
protein
difficult
assert
cell
import
reduct
howev
base
result
present
figur
abl
conclud
least
andor
cell
import
reduct
hcv
core
protein
therefor
elucid
mechan
hcv
protein
clearanc
investig
cell
epitop
also
immunocompet
cell
requir
interestingli
treatmentbut
treatmenteffici
induc
hcvspecif
activ
cell
respons
differ
efficaci
could
one
possibl
caus
hcv
structur
protein
core
protein
rvvcn
construct
may
caus
differ
saito
et
al
report
inject
plasmid
construct
encod
core
protein
induc
specif
ctl
respons
balbc
mice
reportedli
ctl
activ
core
envelop
protein
complet
absent
transgen
mice
immun
plasmid
encod
hcv
structur
protein
corespecif
ctl
activ
present
transgen
mice
immun
plasmid
encod
hcv
core
contrast
recombin
vaccinia
viru
express
differ
region
hcv
polyprotein
inject
balbc
mice
hcv
core
protein
markedli
suppress
vacciniaspecif
ctl
respons
thu
hcv
core
protein
may
immunomodulatori
function
base
report
result
hypothes
caus
underli
effect
treatment
follow
rvv
construct
includ
core
envelop
protein
core
protein
immunesuppress
effect
ctl
induct
therefor
suggest
exclus
core
envelop
antigen
immunogen
one
import
factor
hcv
vaccin
design
interestingli
immun
rapidli
suppress
inflammatori
respons
howev
immun
either
rvv
see
figur
result
indic
may
modul
inflamm
via
innat
immun
well
via
acquir
immun
reportedli
tolllik
receptor
tlr
depend
recognit
pathway
play
role
recognit
poxvirus
also
implic
recognit
vaccinia
viru
find
indic
tlr
dendrit
cell
may
modul
immunosuppress
effect
model
hcv
infect
howev
examin
hypothesi
requir
find
patholog
symptom
hcv
transgen
mice
complet
block
intraven
inject
tnfa
neutral
antibodi
indic
progress
chronic
hepat
depend
inflammatori
cytokin
serum
rather
hcv
protein
level
hepatocyt
lymphocyt
macrophag
hepatocyt
adipocyt
produc
tnfa
hcvinfect
patient
elev
level
tnfa
cytokin
also
contribut
mainten
hepatosteatosi
mice
fed
highfat
diet
product
tnfa
elev
obes
mice
due
low
grade
inflammatori
respons
caus
lipid
accumul
find
indic
cytokin
respons
hcvtrigger
hepatosteatosi
anticytokin
neutral
potenti
treatment
chronic
hepat
antivir
therapi
success
reduct
macrophag
number
might
due
induct
apoptosi
vaccinia
viru
vitro
infect
previou
report
understand
mechan
respons
reduct
number
macrophag
perform
anoth
experi
confirm
whether
macrophag
infect
vaccinia
viru
inocul
howev
base
pcr
analys
vaccinia
viru
dna
present
liver
tissu
contain
macrophag
figur
furthermor
apoptosi
macrophag
detect
liver
sampl
data
shown
base
result
unlik
reduct
number
macrophag
due
apoptosi
induc
vaccinia
viru
infect
although
reduc
number
macrophag
precis
mechan
still
unknown
examin
elucid
mechan
requir
conclus
find
demonstr
promis
candid
hcv
vaccin
therapi
addit
find
studi
indic
immun
use
prevent
hcv
infect
antivir
therapi
ongo
hcv
infect
hcv
cdna
nt
full
genom
hcv
cdna
nt
clone
blood
sampl
taken
patient
chronic
activ
hepat
text
infecti
titer
blood
sampl
previous
report
transgen
mice
bred
transgen
mice
purchas
jackson
laboratori
produc
transgen
mice
design
mxcre
mxcre
mice
respect
cre
express
liver
mice
induc
intraperiton
inject
polyinosin
acidpolycytidyl
acid
poli
c
ge
healthcar
uk
ltd
buckinghamshir
england
ml
poli
c
solut
mgml
phosphatebuff
salin
pb
inject
three
time
interv
anim
care
experiment
procedur
perform
accord
guidelin
establish
tokyo
metropolitan
institut
medic
scienc
subcommitte
laboratori
anim
care
tissu
sampl
fix
paraformaldehyd
pb
embed
paraffin
section
thick
stain
hematoxylin
eosin
h
e
stain
period
acidschiff
stain
azan
stain
silver
oilredo
also
perform
visual
glycogen
degener
fibril
reticular
fiber
degener
lipid
degener
respect
immunohistochem
stain
unfix
frozen
liver
section
fix
paraformaldehyd
min
incub
block
buffer
bovin
serum
albumin
pb
min
room
temperatur
subsequ
section
incub
biotinyl
mous
antihcv
core
monoclon
antibodi
h
room
temperatur
wash
pb
section
incub
streptavidinalexa
fluor
invitrogen
nuclei
stain
dapi
fluoresc
observ
use
confoc
laser
microscop
laser
scan
microscop
carl
zeiss
plasmid
vector
contain
hybrid
promot
within
hemagglutinin
gene
region
vaccinia
viru
reconstruct
plasmid
pbm
vector
separ
fulllength
cdna
encod
either
hcv
structur
protein
nonstructur
protein
hcv
protein
clone
hcv
strain
genotyp
rna
rtpcr
cdna
insert
separ
vector
downstream
hybrid
promot
final
design
recombin
plasmid
figur
transfect
primari
rabbit
kidney
cell
infect
multipl
infect
viruscel
mixtur
harvest
h
initi
transfect
scrap
mixtur
frozen
use
hemagglutininneg
recombin
virus
clone
previous
describ
name
insert
hcv
protein
gene
genom
confirm
direct
pcr
express
protein
recombin
virus
confirm
western
blot
analysi
titer
determin
use
standard
plaqu
assay
cell
data
shown
mean
sd
data
analyz
use
nonparametr
mannwhitney
kruskalw
test
anova
appropri
graphpad
prism
macintosh
graphpad
use
analys
p
valu
consid
statist
signific
tabl
incid
hepatocellular
carcinoma
male
femal
transgen
mice
day
poli
c
inject
text
support
inform
includ
materi
method
refer
docx
